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Abstract The integrin etnb/33-mediated redistribution of the ty- 
rosine kinases pp125 rAg and pp60 src and the small GTP-binding 
proteins CDC42Hs and RaplB from the membrane skeleton to 
the cytoskeleton was found to be reversible: upon prolonged plate- 
let aggregation (up to 15 rain) induced by the thrombin-receptor 
activating peptide (TRAP) these signalling proteins dissociated 
from the cytoskeleton and reappeared in the membrane skeleton. 
Addition of the extracellular Ca 2+ chelator EGTA and the intra- 
cellular Ca 2+ chelator BAPTA/AM 30 s after TRAP allowed 
platelet aggregation and the association of pp125 rAK, pp60 s'c, 
CDC42Hs and RaplB with the cytoskeleton, but prevented their 
dissociation from the cytoskeleton. The results indicate that the 
prolonged elevation of cytosolic Ca 2+ in stimulated platelets leads 
to the dissociation of signalling proteins from the eytoskeleton. 
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1. Introduction 
Resting platelets have 40-50% of their actin content in the 
form of filaments in a loose network throughout the cytoplasm 
as well as in the membrane skeleton (reviewed by Fox in [1]). 
When platelets are aggregated, there is a rapid increase in actin 
polymerisation to 70-80% of total platelet actin. This is associ- 
ated with an extensive reorganisation of filamentous actin into 
networks at the periphery of the cell and into bundles in filopo- 
dia that contribute to the formation of the cytoskeleton. Several 
regulatory proteins in platelets are known to associate with the 
actin-rich cytoskeleton in a manner dependent on activation 
and cross-linking of the integrin e.uB3. These include the inte- 
grin %tf13 itself [2-5], protein tyrosine kinases such as pp60 st" 
[6--12] and pp60 c-v~s [12], the protein tyrosine pbosphatase SH- 
PTP1 [13], small molecular weight GTP-binding proteins like 
Rho A [14], RaplB [15,16], Rap2B [17] and CDC42Hs (submit- 
ted for publication) and other signalling proteins [6,7]. This 
complex of specific signalling proteins might regulate integrin- 
actin interaction i  aggregating platelets. Little is known about 
the regulation of the cytoskeletal ssociation of these proteins. 
In the present study we demonstrate hat the cytoskeletal sso- 
ciation of the protein tyrosine kinases pp125 yAK and pp60 src 
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and the small GTP-binding proteins CDC42HS and RaplB is 
completely reversed upon prolonged platelet aggregation. The 
regulation of this process by Ca 2+ was studied. 
2. Experimental 
2.1. Materials 
Monoclonal antibodies against pp 125 •aK and pp60 s" were from Up- 
state Biotechnology Inc. (Lake Placid, NY). LA 045, a monoclonal 
antibody recognising rap 1B was obtained from Quality Biotech 
(Camden, NJ). The horseradish peroxidase conjugated secondary anti- 
bodies were from Amersham (Braunschweig, Germany). Apyrase, 
ADP, EGTA, acetylsalicylic acid, sodium orthovanadate, f tal bovine 
serum, Triton X-100, leupeptin, pepstatin A, aprotinin, and phen- 
ylmethylsulfonyl fluoride were from the Sigma (St. Louis, MO). 
BAPTA/AM (1,2-bis-(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic 
acid tetra-(acetoxymethyl)-ester) was from Calbiochem (La Jolla, CA). 
Tween 20 and the reagents for electrophoresis were obtained from 
BioRad (Richmond, CA). The chemiluminescence-based Western blot 
detection system ECL was from the Amersham Corp. (Buckingham- 
shire, UK). The thrombin-receptor activating peptide, 'TRAP' 
(SFLLRN) was custom synthesised by Dr. Arnold (Max Planck Insti- 
tute, Martinsried, Germany). 
2.2. Platelet experiments 
Washed human platelets were prepared as described previously [l8]. 
Aliquots (1.5 ml) of washed platelet suspension (109 platelets/ml) were 
incubated whilst stirring (1800 rpm) at 37°C in a LABOR aggregometer 
(Fresenius, Bad Homburg, Germany) for 1 min. CaC12 (50 BM) was 
added 15 s before TRAP (10/~M), Aggregation was measured by the 
change of the light transmission (%). In parallel samples BAPTA/AM 
(100 ¢tM) and EGTA (5 raM) were added 30 s after TRAE 
2.3. Preparation of platelet eytoskeleton and membrane skeleton 
Cytoskeletal fractions were prepared by using a modification of the 
method escribed by Phillips et al. [2]. Briefly, platelet suspensions (1.5 
ml) were lysed before or at various intervals after agonist addition by 
adding equal volumes of ice-cold 2 x Triton lysis buffer (pH 7.5) con- 
taining 100 mM Tris-HCl, 2% Triton X-100, 10 mM EGTA, 10 mM 
EDTA, 2 mM sodium orthovanadate, 20 mM leupeptin, 2 rnM phen- 
ylmethylsulfonyl fluoride, 20,uM pepstatin A and 0.56 trypsin inhibitor 
unit (t.i.u.)/ml aprotinin. Samples (3 ml) were vortexed for 10 s, left on 
ice for 30 rain and spun at 15,600 x g for 15 min at 4°C. The pellets were 
washed once in 1 x Triton X-100 (1%) lysis buffer. Pellets were resus- 
pended in 300/11 gel electrophoresis sample buffer. 
To obtain the membrane skeletal fraction [19], supernatants of deter- 
gent extracts were further centrifuged at 100,000 x g for 2.5 h at 4°C 
in a Beckman ultracentrifuge (L5-50) with a 70.1 Ti rotor. The pellets 
were resuspended in 300 ml gel electrophoresis sample buffer. The 
Triton-soluble supernatant fractions were mixed at a ratio of 4 : 1 with 
5 x sample buffer. 
2.4. Immunoblotting 
Platelet proteins were separated by electrophoresis using 12% SDS- 
polyacrylamide gel. Proteins were electrophoretically transferred to 
Immobilon-P VDF membranes (Millipore Corp., Bedford, MA) by 
using the Nova Blot semidry system (Pharmacia LKB Biotechnology, 
Bromma, Sweden) and the procedure recommended bythe manufac- 
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turer. Residual sites on the membranes were blocked by incubating the 
blots for 1 h at room temperature with 20% (v/v) fetal bovine serum in 
20 mM Tris-HC1, pH 7.4, 150 mM NaCI and 0.3% Tween 20. The blots 
were cut horizontally according to the molecular weights of pp125 yAK, 
pp60 src, CDC42Hs and RaplB, and incubated for 1 h with one of the 
following primary antibodies: (a) anti-pp125 FAK mAb (1:2000), 
(b) anti-pp60 s'c mAb (1 : 6000), (c) anti-CDC42Hs polyclonal ntibody 
(1:200), and (d) LA045 (1 : 100,000). Following washing, the blots were 
incubated for 45 min with peroxidase-labeled sheep anti- mouse IgG 
(1 : 10,000) or goat anti-rabbit IgG (for CDC42Hs). After 3 washes of 
the blot, antibody binding was detected using the enhanced chemilu- 
miniscence (ECL) system (Amersham) and bands were quantified by 
laser densitometry (Ultroscan XL, Pharmacia). 
2.5. Cytoskeletal proteins 
To analyse the amount of actin in the cytoskeleton and the prote- 
olytic cleavage of actin-binding protein (ABP) and talin, platelet pro- 
teins were separated on a 6% SDS-PAGE slab gel, followed by staining 
of the gel with 0.2% Coomassie brilliant blue, destaining and drying. 
The amount of actin was quantified by laser densitometry. 
3. Results 
Platelets were aggregated with TRAP for 15 min. Aggrega- 
tion was maximal at 5 min and decreased by 34,7 + 1.3% 
(mean + S.D., n -- 3) after 15 min of stimulation (see also Fig. 
1, tracing A). Cytoskeleton, membrane skeleton and soluble 
fractions were isolated from platelets aggregated for 0, 2, 5, 10 
and 15 min and studied for the presence of pp125 yAK, pp60 s' ,  
RaplB and CDC42Hs by immunoblotting. 
The immunoblot in Fig. 2 (first five lanes on the left) shows 
the kinetic of pp125 yAK association with the cytoskeleton of 
aggregated platelets. There was no or very little pp125 FA~ de- 
tectable in the cytoskeleton of resting platelets (0 rain). In plate- 
lets stimulated for 2 min, 9.5% of total pp125 vA~ was present 
in the cytoskeleton. Upon prolonged platelet stimulation (15 
min) pp 125 FAK disappeared from the cytoskeleton, and this was 
paralleled by partial platelet disaggregation. I  the membrane 
skeleton pp125 yAK decreased from 10% to 5.4% of total protein 
2 min after stimulation with TRAP and returned to control 
values 15 rain after stimulation (Fig. 3A). 
Similar to pp125 va~ (Figs. 2 and 3A), two small GTP-binding 
proteins, RaplB and CDC42Hs, translocated to the cytoskele- 
ton 2 rain after platelet aggregation i duced by TRAP and then 
disappeared from the cytoskeleton upon prolonged aggregation 
of platelets for 15 min (Fig. 3B and C). In the membrane 
skeleton, RaplB and CDC42Hs decreased from 15% and 9% 
to 10% and 1% of total protein, respectively, 2 min after stim- 
ulation with TRAP, and returned to control values 15 min after 
stimulation. Unlike the proteins mentioned above, pp60 s'c (10% 
of total cellular pp60 src) was detected in the cytoskeleton of 
resting platelets. Upon platelet aggregation cytoskeleton-asso- 
ciated pp60 s" increased to 19% 2 min after stimulation, fol- 
lowed by a decline to the control evel upon prolonged platelet 
aggregation for 15 min (Fig. 3D). 
In order to further study the regulation of dissociation of 
these proteins from the cytoskeleton, we next asked whether the 
level of cytosolic free calcium might determine this process. 
Platelet activation induced by thrombin receptor activation in- 
duces Ca2+-mobilisation from intracellular stores and Ca 2÷- 
entry through the plasma membrane, resulting in a very rapid 
(<1 s) increase of cytosolic Ca 2+ followed by a slow decrease 
to a new steady-state Ca2+, the 'Ca2+-plateau ' (reviewed in [20]). 
BAPTA/AM and EGTA chelate intra- and extracellular Ca 2+, 
respectively, and block cytosolic Ca2+-transients in platelets 
[21]. When added 30 s after TRAP, these substances will not 
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Fig. 1. Platelet aggregation for 15 rain induced by TRAP. Effect of BAPTA/AM and EGTA. Platelets were aggregated as described in section 2. 
BAPTA/AM (100/tM) and EGTA (5 mM) were added (arrow) 30 s after TRAP (tracing B). In control tracing (A) DMSO was added at the same 
time. The figure is representative of three different experiments. 
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Fig. 2. Cytoskeletal ssociation of pp125 yAK in platelets aggregated for 15 min. Effect of BAPTA/AM and EGTA. Platelet aggregation was induced 
by TRAP (10 pM). DMSO (control), or BAPTA/AM (100 ¢tM) and EGTA (5 raM) were added 30 s after TRAR The Triton-insoluble cytoskeletal 
proteins were isolated from the samples at the indicated times, separated by SDS-PAGE and immunoblotted using the anti-pp125 FAK antibody. The 
experiment is representative of four different experiments. 
addition of BAPTA/AM (100/.tM) and EGTA (5 pM) 30 s after 
TRAP all proteins tudied (pp125 yAK, pp60 st', CDC42Hs and 
Rap 1 B) still translocated tothe cytoskeleton 2 min after platelet 
stimulation. Under these conditions, maximal platelet aggrega- 
tion at 5 rain was reduced by 18 + 2% (mean + S.D.) in compar- 
ison to control but it did not further decline (Fig. 1, tracing B). 
Interestingly, upon continued stimulation for 15 rain, the 
amounts of these proteins in the cytoskeleton did not decrease 
but remained elevated (Figs. 2 and 3). These results indicate 
that the sustained elevation of intracellular Ca 2+ after platelet 
stimulation might be responsible for the dissociation of 
pp125 FAK, pp60 s", CDC42Hs and RaplB from the cytoskele- 
ton. 
We also measured the amount of actin in the cytoskeleton 
under these conditions. Cytoskeletal actin increased from 
41 + 7% to 81 + 9.2% 2 min after aggregation induced by 
TRAR Upon prolonged platelet aggregation for 15 min the 
amount of actin in the cytoskeleton returned to the resting 
value (40 + 5.9%) whereas in platelets treated with BAPTA and 
EGTA the cytoskeletal actin remained elevated (84 + 8.7%) 
(mean _+ S.D., n = 3). 
4. Discussion 
In addition to the previously reported aggregation-depend- 
ent associaton of pp60 srC [6-12], RaplB [15,16] and CDC42Hs 2 
with the cytoskeleton, we found in the present study also an 
aggregation-dependent translocation of pp125 yAK to the plate- 
let cytoskeleton. As the increased binding of CDC42Hs, 
pp125 vA~, pp60 sr~ and RaplB to the cytoskeleton was paral- 
leled by an increase in cytoskeletal ctin, it is conceivable that 
these proteins associate with actin filaments that are newly 
formed in aggregating platelets. In previous tudies it has been 
shown that stimulation of actin polymerisation i activated 
platelets regulates the interaction of signalling proteins with the 
cytoskeleton. Prevention of increased actin polymerisation i
aggregated platelets by cytochalasin D treatment resulted in 
inhibition of cytoskeletal ssociation of CDC42Hs 2 and pp60 s" 
[10]. Addition of DNase (which depolymerises F-actin) to the 
Triton-lysate of aggregated platelets also dramatically reduced 
the amount of cytoskeletal-associated pp60 st" [8]. The present 
study shows to our knowledge for the first time that actin 
filamentisation and the translocation of protein tyrosine ki- 
nases (pp125 yAK and pp60 srC) and small GTP-binding proteins 
(CDC42Hs and RaplB) from the membrane skeleton to the 
cytoskeleton i aggregated platelets is a completely reversible 
physiological process. 
Chelation of extracellular and cytosolic Ca 2+ subsequent to 
platelet aggregation i hibited markedly the cytoskeletal ssoci- 
ation of RaplB, but less the association of pp125 yAK, pp60 st" 
and CDC42Hs 2 and 5 min after platelet aggregation. In agree- 
ment with our results Fischer et al. [16] have reported that 
RaplB translocation to the cytoskeleton is dependent on ex- 
tracellular Ca 2+ while that of pp60 src is not. Hence, these find- 
ings indicate a different regulation for the cytoskeletal ssocia- 
tion of RaplB compared to other proteins. The results with 
chelation of extracellular and cytosolic Ca 2+ subsequent to 
TRAP-stimulation reveal that sustained elevation of cytosolic 
Ca 2+ is responsible for the decrease ofcytoskeletal ctin and the 
dissociation of signalling proteins from the cytoskeleton. Pro- 
longed increase of cytosolic Ca 2+ might activate calpain I lead- 
ing to the hydrolysis of cytoskeletal proteins like actin-binding 
protein (ABP), spectrin, talin (p235) and ~-actinin which are 
involved in the organisation of actin filaments into their three- 
dimensional structure. However, we did not observe calpain 
activation in platelets aggregated for 15 min, as judged from 
proteolysis of ABP and p235 (data not shown). Hence, calpain 
activation is unlikely to be the cause for the decrease of cy- 
toskeletal actin and dissociation of signalling proteins from the 
cytoskeleton upon prolonged platelet aggregation. Gelsolin 
might be another possible candidate responsible for the loss of 
cytoskeletal ctin filaments during prolonged platelet aggrega- 
tion. Gelsolin binds to filamentous actin in the presence of 
micromolar Ca 2+ concentration leading to depolymerisation f 
actin filaments and disruption of the actin network [22,23]. 
Notabely, gelsolin activation requires a sustained increase in 
free Ca 2+ [24], rather than a rapid and transient increase [25]. 
Chelation of cytosolic Ca 2+ by BAPTA/AM and EGTA might 
result in a diminished actin-gelsolin complex formation and 
hence unchanged cytoskeletal actin upon prolonged platelet 
aggregation. 
In various studies it has been suggested that the aggregation- 
induced reorganisation of the actin cytoskeleton may provide 
a functional platform for the physiological ctivity of the vari- 
ous signalling proteins that translocate to the cytoskeleton. Our 
data show that, during prolonged aggregation, the amounts of 
cytoskeletal ctin, pp 125 yAK, Rap 1 B, CDC42Hs and pp60 st" in 
the cytoskeleton return to the basal level present in resting 
platelets. Interestingly, this process was associated with partial 
platelet disaggregation. These results indicate that sustained 
elevation of cytosolic Ca 2+ in stimulated platelets plays a role 
in the destabilisation of platelet aggregates by diminishing the 
association of signalling proteins with the actin-rich cytoskele- 
ton. Chelation of Ca 2+ which preserved the actin-rich cytoskel- 
eton and the eytoskeletal ssociation of signalling proteins led 
to irreversible platelet aggregates which were stable. 
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Fig. 3. Distribution of pp125 ~A~ (A), RaplB (B), CDC42Hs (C) and pp60 s'c (D) in the cytoskeleton and membrane skeleton during platelet 
aggregation i duced by TRAP. Effect of BAPTA/AM and EGTA. Platelet aggregation was induced by TRAP (10/.tM). DMSO (control) or 
BAPTA/AM (100 ~tM) and EGTA (5 raM) were added 30 s after TRAP. The cytoskeletal nd membrane skeletal fractions were isolated at the 
indicated time points. Proteins in each fraction were separated by SDS-PAGE and immunoblotted using the respective antibodies. Data are 
mean + S.D. of three different experiments. Open symbols-control; c osed symbols = BAPTA/AM and EGTA. *P < 0.05; **P < 0.01 as compared 
to control at 15 min. 
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